Medical Devices: Page 29
-
Baxter to close Massachusetts site, lay off 59 people
News of the cuts comes 13 months after the company outlined plans to eliminate 3,000 positions.
By Nick Paul Taylor • March 7, 2024 -
Vicarious presses forward with soft tissue robot despite struggles
The company detailed upcoming milestones for its robotic surgery system on a fourth-quarter earnings call.
By Susan Kelly • March 6, 2024 -
Explore the Trendline➔
Sitthiphong via Getty ImagesTrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Smiths Medical recalls nearly 86,000 syringe pumps over software problem
The company fixed the issues, which are linked to one reported injury, by updating its software.
By Nick Paul Taylor • March 6, 2024 -
Dexcom receives FDA clearance for first OTC glucose sensor
The diabetes tech firm is tailoring its software to the 25 million people in the U.S. who have Type 2 diabetes and do not use insulin.
By Nick Paul Taylor • March 6, 2024 -
Haemonetics to buy Attune Medical for $160M
Attune’s device to help cool the esophagus during radiofrequency ablation procedures is a key piece of the acquisition.
By Susan Kelly • March 5, 2024 -
BD starts trial of vascular covered stent in peripheral arterial disease
Peripheral vascular disease is one of six key platforms BD is targeting for growth.
By Nick Paul Taylor • March 5, 2024 -
Medtronic estimates up to 40 job losses in Ireland due to restructuring
The company confirmed the potential job reductions from shutting down its ventilator product lines in an email to MedTech Dive.
By Ricky Zipp • March 5, 2024 -
Dexcom, Novo Nordisk call for FDA input on digital diabetes detection devices
The companies want clarity on what evidence would be needed for new technologies to detect undiagnosed Type 2 diabetes or prediabetes.
By Nick Paul Taylor • March 4, 2024 -
Baxter considers selling kidney care unit to private equity
The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.
By Elise Reuter • March 4, 2024 -
GE Healthcare recalls incubators due to risk of newborns falling
The Food and Drug Administration labeled the recall as a Class I event after a serious injury was reported.
By Nick Paul Taylor • March 4, 2024 -
Boston Scientific gains FDA nod for drug-coated coronary balloon
BTIG analyst Marie Thibault said physicians could rapidly adopt the first-of-its-kind device.
By Susan Kelly • March 1, 2024 -
Q&A
Abbott leader on the ‘hype’ and ‘reality’ of pulsed field ablation
Christopher Piorkowski, chief medical officer for the electrophysiology business, talks about the high expectations for the new atrial fibrillation treatment.
By Susan Kelly • March 1, 2024 -
FDA responds to claim breast implant removal is ‘reasonable’ to cut cancer risk
Experts convened by the American Association of Plastic Surgeons concluded it may be “considered reasonable” to remove textured breast implants to reduce the risk of a rare cancer.
By Nick Paul Taylor • Updated March 4, 2024 -
Medtronic asks ITC to stop sales, imports of Axonics devices
The complaint is the latest move in a long-running patent fight between the two companies regarding neuromodulation devices.
By Nick Paul Taylor • March 1, 2024 -
Insulet sizes up competition as Tandem, Medtronic plan new insulin patch-pumps
Insulet CEO Jim Hollingshead said the company is “very confident” in its competitive position as rivals develop their own patch pumps.
By Elise Reuter • Feb. 29, 2024 -
Integra Lifesciences CEO Jan De Witte to retire
The company is working to restart a factory in Boston after problems at the plant led to a sweeping recall in 2023. De Witte will stay with Integra until it finds a successor.
By Elise Reuter • Feb. 29, 2024 -
J&J’s pulsed field ablation system secures European approval
The device maker will vie against rivals Boston Scientific and Medtronic in the market for the new treatment for atrial fibrillation.
By Susan Kelly • Feb. 29, 2024 -
Philips names Stryker’s Charlotte Hanneman as CFO
Abhijit Bhattacharya, who took over as CFO in 2015 and has spent 37 years with the company, will step down in October.
By Nick Paul Taylor • Feb. 29, 2024 -
J&J begins enrolling patients in Laminar LAA pivotal trial
The new device is meant to compete with systems offered by Boston Scientific and Abbott that address blood clot risk in atrial fibrillation.
By Susan Kelly • Feb. 28, 2024 -
BD life sciences president Dave Hickey to retire July 1
The company has yet to name Hickey’s replacement but plans to have a successor in place before the executive retires.
By Nick Paul Taylor • Feb. 28, 2024 -
Retrieved from Hologic on February 28, 2024
Hologic’s radiographic markers targeted in FDA safety communication
The agency has seen reports the implants can move out of position and break through the skin.
By Nick Paul Taylor • Feb. 28, 2024 -
Henry Schein expects cyber incident costs to continue in 2024
The company reported a $350 million to $400 million reduction in Q4 sales due to the incident, which forced it to take some systems offline.
By Elise Reuter • Feb. 27, 2024 -
Integra Lifesciences to cut about 60 jobs as it closes Indiana site
Manufacturing will be transferred to a plant in Maryland as part of a strategy to bolster operational efficiency, a company spokesperson said.
By Susan Kelly • Feb. 27, 2024 -
Virtual Incision wins FDA de novo nod for miniaturized surgical robot
The device weighs about two pounds and fits into a tray that can be carried between operating rooms.
By Nick Paul Taylor • Feb. 27, 2024 -
Medtronic will transfer or offer comprehensive support to workers affected by ventilator exit
The company did not state how many people may be affected by the decision, announced last week, to shut down its ventilator product lines.
By Ricky Zipp • Feb. 26, 2024